Xalkori 150 MG Oral Pellet

RxCUI: 2670170
RxNorm name: Xalkori 150 MG Oral Pellet
Display name: Xalkori 150 MG Oral Pellet
Full name: Xalkori 150 MG Oral Pellet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Xalkori	CRIZOTINIB	Pfizer Laboratories Div Pfizer Inc	2a51b0de-47d6-455e-a94c-d2c737b04ff7	2025-07-22	Warnings, Adverse reactions	Exact identifier rxcui: 2670170

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
2a51b0de-47d6-455e-a94c-d2c737b04ff7	Xalkori 150 MG Oral Pellet	SY	46	These highlights do not include all the information needed to use XALKORI ® safely and effectively. See full prescribing information for XALKORI. XALKORI ® (crizotinib) capsules, for oral use XALKORI ® (crizotinib) oral pellets Initial U.S. Approval: 2011	20250722
2a51b0de-47d6-455e-a94c-d2c737b04ff7	crizotinib 150 MG Oral Pellet [Xalkori]	SBD	46	These highlights do not include all the information needed to use XALKORI ® safely and effectively. See full prescribing information for XALKORI. XALKORI ® (crizotinib) capsules, for oral use XALKORI ® (crizotinib) oral pellets Initial U.S. Approval: 2011	20250722
2a51b0de-47d6-455e-a94c-d2c737b04ff7	XALKORI 150 MG Oral Pellet	PSN	46	These highlights do not include all the information needed to use XALKORI ® safely and effectively. See full prescribing information for XALKORI. XALKORI ® (crizotinib) capsules, for oral use XALKORI ® (crizotinib) oral pellets Initial U.S. Approval: 2011	20250722